Cargando…

Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study

OBJECTIVE: To evaluate the clinical features and inflammatory cytokines of dry eye disease (DED) in patients with schizophrenia. METHODS: This is a case-control study. The modified self-rating depression scale (M-SDS) and the ocular surface disease index (OSDI) were used to evaluate the symptoms of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiankun, Wei, Zhengjiang, Wang, Leying, Xu, Xizhan, Wei, Zhenyu, Zheng, Panpan, Cao, Kai, Zhang, Zijun, Chen, Kexin, Liang, Qingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864171/
https://www.ncbi.nlm.nih.gov/pubmed/35223927
http://dx.doi.org/10.3389/fmed.2022.831337
_version_ 1784655398563741696
author Chen, Qiankun
Wei, Zhengjiang
Wang, Leying
Xu, Xizhan
Wei, Zhenyu
Zheng, Panpan
Cao, Kai
Zhang, Zijun
Chen, Kexin
Liang, Qingfeng
author_facet Chen, Qiankun
Wei, Zhengjiang
Wang, Leying
Xu, Xizhan
Wei, Zhenyu
Zheng, Panpan
Cao, Kai
Zhang, Zijun
Chen, Kexin
Liang, Qingfeng
author_sort Chen, Qiankun
collection PubMed
description OBJECTIVE: To evaluate the clinical features and inflammatory cytokines of dry eye disease (DED) in patients with schizophrenia. METHODS: This is a case-control study. The modified self-rating depression scale (M-SDS) and the ocular surface disease index (OSDI) were used to evaluate the symptoms of depression and DED, respectively. Lipid layer thickness (LLT), partial blink rate (PBR), meibomian gland loss (MGL), tear break-up time (TBUT), corneal fluorescein staining, Schirmer I-test, and eyelid margin abnormalities were also measured. A multiplex ELISA Quantibody array was used to detect the inflammatory cytokines in the tears of all participants. RESULTS: Forty schizophrenic patients and 20 control subjects were included. The mean age was 45.0 ± 9.5 years (range, 22–63 years) in schizophrenic patients and 45.4 ± 16.2 years (range, 23–76 years) in controls (P = 0.914). The ratio of male to female was 1.1 in schizophrenic patients and 1.0 in controls (P = 0.914). Ten women (52.6%) with schizophrenia and 2 (20%) in the control group (P = 0.096) were menopausal or post-menopausal. The OSDI [0.0 (0.0–4.2) vs. 7.3 (2.1–14.6)] and TBUT [4.5 (3.0–6.0) vs. 10.0 (3.5–11.0)] were significantly lower in patients with schizophrenia than in controls (P = 0.003 and P = 0.009, respectively). The rate of MGL [36.5 (17.5–47.5) vs. 8.5 (0.0–17.5)] increased in schizophrenic patients (P < 0.001). Among pro-inflammatory cytokines, the levels of interleukin (IL)-1α, IL-6, IL-11, IL-12A, IL-15, IL-17A, and granulocyte colony-stimulating factor (G-CSF) in tears were elevated in the schizophrenia group (all P < 0.01). Most of the chemokines examined were at increased levels in the tears of schizophrenics (all P < 0.05). The levels of matrix metalloproteinases-9 (MMP-9) and intercellular adhesion molecule-1 (ICAM-1) were also higher in the schizophrenic patients (all P < 0.001). The concentrations of IL-1Ra, tissue-inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in the schizophrenia group were decreased (all P < 0.001). In schizophrenic patients, the level of CCL2 in tears was positively correlated with OSDI (R = 0.34, P = 0.03). The increasing TIMP-1 and decreasing IL-5 were correlated with increasing LLT (R = 0.33, P = 0.035; R = −0.35, P = 0.027, respectively). The level of ICAM-1 was then positively correlated with partial blink rate (PBR) (R = 0.33, P = 0.035). There was a negative correlation between IL-8 and the Schirmer I-test (R = −0.41, P = 0.009). CONCLUSIONS: Patients with schizophrenia were more likely to experience asymptomatic DED, with mild symptoms and obvious signs. The inflammatory cytokines in the tears of schizophrenic patients differed greatly from that of non-schizophrenic patients.
format Online
Article
Text
id pubmed-8864171
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88641712022-02-24 Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study Chen, Qiankun Wei, Zhengjiang Wang, Leying Xu, Xizhan Wei, Zhenyu Zheng, Panpan Cao, Kai Zhang, Zijun Chen, Kexin Liang, Qingfeng Front Med (Lausanne) Medicine OBJECTIVE: To evaluate the clinical features and inflammatory cytokines of dry eye disease (DED) in patients with schizophrenia. METHODS: This is a case-control study. The modified self-rating depression scale (M-SDS) and the ocular surface disease index (OSDI) were used to evaluate the symptoms of depression and DED, respectively. Lipid layer thickness (LLT), partial blink rate (PBR), meibomian gland loss (MGL), tear break-up time (TBUT), corneal fluorescein staining, Schirmer I-test, and eyelid margin abnormalities were also measured. A multiplex ELISA Quantibody array was used to detect the inflammatory cytokines in the tears of all participants. RESULTS: Forty schizophrenic patients and 20 control subjects were included. The mean age was 45.0 ± 9.5 years (range, 22–63 years) in schizophrenic patients and 45.4 ± 16.2 years (range, 23–76 years) in controls (P = 0.914). The ratio of male to female was 1.1 in schizophrenic patients and 1.0 in controls (P = 0.914). Ten women (52.6%) with schizophrenia and 2 (20%) in the control group (P = 0.096) were menopausal or post-menopausal. The OSDI [0.0 (0.0–4.2) vs. 7.3 (2.1–14.6)] and TBUT [4.5 (3.0–6.0) vs. 10.0 (3.5–11.0)] were significantly lower in patients with schizophrenia than in controls (P = 0.003 and P = 0.009, respectively). The rate of MGL [36.5 (17.5–47.5) vs. 8.5 (0.0–17.5)] increased in schizophrenic patients (P < 0.001). Among pro-inflammatory cytokines, the levels of interleukin (IL)-1α, IL-6, IL-11, IL-12A, IL-15, IL-17A, and granulocyte colony-stimulating factor (G-CSF) in tears were elevated in the schizophrenia group (all P < 0.01). Most of the chemokines examined were at increased levels in the tears of schizophrenics (all P < 0.05). The levels of matrix metalloproteinases-9 (MMP-9) and intercellular adhesion molecule-1 (ICAM-1) were also higher in the schizophrenic patients (all P < 0.001). The concentrations of IL-1Ra, tissue-inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in the schizophrenia group were decreased (all P < 0.001). In schizophrenic patients, the level of CCL2 in tears was positively correlated with OSDI (R = 0.34, P = 0.03). The increasing TIMP-1 and decreasing IL-5 were correlated with increasing LLT (R = 0.33, P = 0.035; R = −0.35, P = 0.027, respectively). The level of ICAM-1 was then positively correlated with partial blink rate (PBR) (R = 0.33, P = 0.035). There was a negative correlation between IL-8 and the Schirmer I-test (R = −0.41, P = 0.009). CONCLUSIONS: Patients with schizophrenia were more likely to experience asymptomatic DED, with mild symptoms and obvious signs. The inflammatory cytokines in the tears of schizophrenic patients differed greatly from that of non-schizophrenic patients. Frontiers Media S.A. 2022-02-09 /pmc/articles/PMC8864171/ /pubmed/35223927 http://dx.doi.org/10.3389/fmed.2022.831337 Text en Copyright © 2022 Chen, Wei, Wang, Xu, Wei, Zheng, Cao, Zhang, Chen and Liang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chen, Qiankun
Wei, Zhengjiang
Wang, Leying
Xu, Xizhan
Wei, Zhenyu
Zheng, Panpan
Cao, Kai
Zhang, Zijun
Chen, Kexin
Liang, Qingfeng
Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study
title Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study
title_full Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study
title_fullStr Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study
title_full_unstemmed Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study
title_short Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study
title_sort dry eye disease in patients with schizophrenia: a case-control study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864171/
https://www.ncbi.nlm.nih.gov/pubmed/35223927
http://dx.doi.org/10.3389/fmed.2022.831337
work_keys_str_mv AT chenqiankun dryeyediseaseinpatientswithschizophreniaacasecontrolstudy
AT weizhengjiang dryeyediseaseinpatientswithschizophreniaacasecontrolstudy
AT wangleying dryeyediseaseinpatientswithschizophreniaacasecontrolstudy
AT xuxizhan dryeyediseaseinpatientswithschizophreniaacasecontrolstudy
AT weizhenyu dryeyediseaseinpatientswithschizophreniaacasecontrolstudy
AT zhengpanpan dryeyediseaseinpatientswithschizophreniaacasecontrolstudy
AT caokai dryeyediseaseinpatientswithschizophreniaacasecontrolstudy
AT zhangzijun dryeyediseaseinpatientswithschizophreniaacasecontrolstudy
AT chenkexin dryeyediseaseinpatientswithschizophreniaacasecontrolstudy
AT liangqingfeng dryeyediseaseinpatientswithschizophreniaacasecontrolstudy